Nick Latimer

Prof of Health Economics at ScHARR, University of Sheffield. Member of NICE Appraisal Committee. Like cycling and have haemophilia.

[Nick Latimer @NRLatimer]

I made a movie about survival analysis and #HTA!

"What about a cure model?", set at Ultradrug Ltd.

https://t.co/WhKdRQhv1R

It's got a bit of KMunicate (@tmorris_mrc ), some stpm2 (@pclambert123, @MJRutherford9) and there's a special reward for anyone who makes it to the end

[Nick Latimer @NRLatimer]

@BasarirH Thanks Hasan!

[SCHARR Knowledge Exchange @SCHARR_KE]

👩‍🏫 Join us at the #ISPORSummit for Prof. Nick Latimer's @NRLatimer talk on "Methods for Causal Inference Using Real-World Data "

📅 Sunday 17 November, 13:15 - 14:50.

💭 Enhance your #RWE knowledge with this insightful conversation.

🔗 https://t.co/GUsYm7DnWC

[Nick Latimer @NRLatimer]

@MJRutherford9 @UoL_Biostats @UoL_Health_Sci Great news and very much deserved, congratulations!

[Nick Latimer @NRLatimer]

Cure Models for HTA: What You Need to Know

Should decision-makers be more willing to use cure models? How do they work? What can go wrong? What on earth are flexible parametric non-mixture cure models??!

Thanks to @MJRutherford9 for writing this with me.
https://t.co/g8sUMVHIOM

[SCHARR HEDS @SCHARRHEDS]

We are currently advertising for an early career researcher with a strong background in statistics/mathematics and an interest in Bayesian statistics and health technology assessment to join us at @SCHARRSheffield
G7, fixed-term until 31 March 2028
https://t.co/bZYaR4VEJo

[NICE DSU @NICE_DSU]

Treatment switching in randomised controlled trials: Trial design, what to adjust for, how, and reporting guidelines. The DSU’s new TSD 24 provides an update to TSD 16 – out now! https://t.co/5NgkwiQjW9

[JY Amy Chang @jy_a_chang]

A publication from my doctoral work with my fantastic and inspiring supervisors Prof Nick Latimer @NRLatimer and Prof Jim Chilcott, and sponsored by the generous @wellcometrust.
@SCHARRSheffield @SCHARRHEDS
#HTA #treatmentsequennces #RWD #causalinference

[Dr. Blythe Adamson @DrBlytheAdamson]

🚨 Helpful how-to evaluate treatment sequences for #HTA by @SCHARRSheffield Amy Chang @NRLatimer

@ph_economics #pharmacoeconomics
https://t.co/t4OBkEwgX6

[ISPORJournals @ISPORJournals]

Research by @NRLatimer and colleagues shows that forcing a marginal hazard ratio to 1 does not accurately assess mean survival difference under individual-level treatment effect waning. More at https://t.co/qKhh6sHLnq. #HEOR #HTA #harzardratio #ValueinHealth

[Dr. Blythe Adamson @DrBlytheAdamson]

If you're too busy to read 4000 words on moving data between countries, listen to my quick summary of key points in the video below.

@VivekSubbiah @NRLatimer #oncology

[Sheffield Cancer Research @TUOS_Cancer]

We are seeking leading cancer researchers to come & join us at Sheffield, in partnership with
@SheffieldHosp. You'll have a package of support inc research staff, consumables & PhD(s) + access to dedicated funding opportunities through
@yorkshirecancer 👉https://t.co/OO0kzTt1iT

[Nick Latimer @NRLatimer]

Some really great opportunities at Sheffield at the moment, including for methodologists.

[The University of Sheffield Jobs @UniOfSheffJobs]

📣 Join the University of Sheffield in the fight against cancer! 🎗️ We're recruiting top-notch cancer research leaders to help us create a future where more people survive and live longer.

Apply now at https://t.co/xqfqAEJtEw

#Cancer #CancerResearch #oncology #epidemiology

[Jonny Broomfield @JonnyBroomfield]

📜Paper📜 in @BrainBehavior with @KRAbrams, @NRLatimer, @MichelaGuglieri, @MJRutherford9 and @Crowther_MJ.

Assessing the CPRD as a data resource for DMD (and other rare disease) natural history models:

✅ Mortality
❓ Intermediate events

https://t.co/V5na3yHCjM

#rarediseases

[John Holmes @JHolmesSheff]

***Fully Funded PhD Studentships*** We have 7 @wellcometrust Studentships in Public Health Economics and Decision Science available.

Check out our website for more information: https://t.co/81RaeaI8Ec

Deadline: 11th December 2023

[SCHARR Knowledge Exchange @SCHARR_KE]

📣 This time next week #ISPOREurope will be in full swing.

🔗 take a look at SCHARR's full academic programme https://t.co/LCr7i8O2QG

😀 We hope you’ll pop by to see us on stand C2-021 in Hall E @ScHARRHEDS @ScHARRSheffield @ISPORorg

#ISPOR2023

[Herbstworkshop Stat. & Epi. Meth. @Herbstworkshops]

12 days left until #HWSmethods2023 in @uni_mainz! Check out the program👇 with keynotes from @nkreif and @NRLatimer. You can still register via [email protected] - no participation fees thanks to @DGEpi_eV, @gmdsEV, @IBSstats, @DGSMP_e_V. #EpiTwitter #StatsTwitter

[Michael Crowther @Crowther_MJ]

A big day 🤩

We've also launched:
👩‍🏫 A free course in survival analysis on our new Youtube channel
💻 A new #Stata package called #morgana for Bayesian flexible survival analysis
🧐 An advert for a new Principal Biostatistician to join the team

#Biostatistics

[Céire Costelloe @ProfCCostelloe]

Nice summary of our session ‘EHR - a good target’ which focussed on research design and methodologies for working with EHR. Great turnout and discussion #RSS2023Conf https://t.co/5Evo0y8WaM

[Michael Sweeting @michaelsweeting]

I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code.
Huge thanks to
@MJRutherford9 @danj_statsguru @NRLatimer @pclambert123 and all co-authors
https://t.co/2sq41tNjNz

[Medical Decision Making @MedDecMak]

A review of survival extrapolation methods with external evidence finds lots of methods, but little in the way of validation #hta #survivalanalysis
@AshBullement @gianlubaio @gemmaeshields @NRLatimer @ScHARRHEDS @stats_UCL @HealthEcon_MCR
https://t.co/F3hFcyEEfI